Fate Therapeutics Inc. (FATE)
NASDAQ · Healthcare
Fate Therapeutics Inc. Income Statement 2011–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||
| Revenue | 6.6M | 13.6M | 63.5M | 96.3M | 55.8M | 31.4M | 10.7M | 4.7M | 4.1M | 4.4M | 2.4M | 971,000 | 2.7M | 1.2M |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | ||||||||||||||
| Operating Income | -147.7M | -210.3M | -190.5M | -308.4M | -217.0M | -128.1M | -100.7M | -67.1M | -42.1M | -32.0M | -27.8M | -17.7M | -13.6M | -13.3M |
| EBITDA | -134.8M | -191.3M | -172.2M | -294.6M | -211.1M | -125.0M | -98.5M | -65.9M | -41.2M | -31.1M | -27.1M | -17.1M | -13.0M | -12.6M |
| Net Income | -136.3M | -186.3M | -160.9M | -281.7M | -212.2M | -173.4M | -98.1M | -66.6M | -43.0M | -33.5M | -30.0M | -20.9M | -14.2M | -13.4M |
| Per Share Data | ||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 119M | 114M | 98M | 97M | 95M | 82M | 76M | 65M | 53M | 41M | 29M | 20M | 1M | — |
Fate Therapeutics Inc. Income Statement — FAQ
Fate Therapeutics Inc. (FATE) income statement over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FATE's income statement history?
The chart and table above show Fate Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.